Similar findings were observed by Bjerrum and her colleagues in 2019.19 From Table 3, a greater proportion (77.4%) of those who were eligible for LF-LAM test had CD4 count less than 200 cells/mm3, according to WHO definition for AHD and therefore recommended a package of care for such patients, which included screening, management and prophylactic treatment of opportunistic infections such as TB, cryptococcal meningitis, toxoplasmosis, et cetera.20 This evidence concerns the gene CD4 and tuberculosis.